1. |
Khan Q,M. Ashfaq,J.Sharif Prevalence of the QT interval prolongation and its risk factors in hospitalized geriatric patients: findings of a single center cross-sectional study in Pakistan, BMC geriatrics, 2025 |
2. |
Khan Q,M. Ashfaq,J.Sharif Comparative assessment of treatment outcomes of empagliflozin add-on metformin and sitagliptin add-on metformin therapies in uncontrolled type 2 diabetes mellitus: findings from an observational study in Pakistan, Journal of Health, Population and Nutrition, 2025 |
3. |
J.Sharif,M. Ashfaq,Khan Q,Mobasher The growing threat of carbapenem and cephalosporin resistance: antimicrobial resistance patterns of who priority pathogens in a tertiary care setting, Journal of Ayub Medical College Abbottabad, 2025 |
4. |
J.Sharif,M. Ashfaq,Khan Q CHIKUNGUNYA FEVER SURVEILLANCE, OUTBREAK INVESTIGATION, RESPONSE AND ITS DETERMINANTS FACTORS IN PESHAWAR, PAKISTAN: A DESCRIPTIVE AND UNMATCHED CASE-CONTROL STUDY, JOURNAL OF AYUB MEDICAL COLLEGE ABBOTTABAD, 2024 |
5. |
M. Ashfaq,J.Sharif,Khan Q,Mobasher Consumption of proton pump inhibitors in outpatients of Gastroenterology Clinics in Khyber Pakhtunkhwa: evidence of inexpedient use, Gastroenterology Review, 2024 |
6. |
Dr Hira Khan,A Ali,Khan Q Questionnaire-Based Study of 392 Women
in Abbottabad, Pakistan, to Evaluate the Types of Cosmetic Products Purchased Between December 2018 and March 2019 and Their Associated Adverse Events, Med Sci Monit Basic Res, 2024 |
7. |
Khan Q Questionnaire-Based Study of 392 Women in Abbottabad, Pakistan, to Evaluate the Types of Cosmetic Products Purchased Between December 2018 and March 2019 and Their Associated Adverse Events, Medical Science Monitor Basic Research, 2024 |
8. |
M. Ashfaq,Mobasher,J.Sharif,Khan Q Effects of long-term proton pump inhibitor use on sexual hormones and sexual and reproductive health in female patients, Endocrine, 2024 |
9. |
I.Amirzada,J.Sharif,Khan Q Potential drug-drug interactions in patients presenting with osteoarthritis to community orthopaedic clinics of Abbottabad, Khyber Pakhtunkhwa: a cross-sectional study, Annales Pharmaceutiques Françaises, 2023 |
10. |
M. Ashfaq,Yasser MSA Alkahraman,Mobasher,J.Sharif,Khan Q Long-Term Proton Pump Inhibitor Therapy and its Effect on Endocrine Hormones in Selected Patient Population, Hormone and Metabolic Research, 2023 |
11. |
J.Sharif,Shujaat A.K, SA Khan,Mobasher,M. Ashfaq,Khan Q Exploring the factors and barriers of healthcare professionals in tertiary care hospitals toward pharmacovigilance: a multicenter study from Khyber Pakhtunkhwa, Pakistan, Current Medical Research and Opinion , 2022 |
12. |
Khan Q Prevalence, predictors and outcomes of potential drug-drug interactions in left ventricular failure: considerable factors for quality use of medicines, Brazilian journal of pharmaceutical sciences, 2020 |
13. |
Khan Q Prevalence of QTc interval prolongation and its associated risk factors among psychiatric patients: a prospective observational study., BMC psychiatry, 2020 |
14. |
Zahid Ali,Khan Q,S Noor Prevalence of QTc interval prolongation and its associated risk factors among psychiatric patients: a prospective observational study, BMC Psychiatry, 2020 |
15. |
Inam ul Haq,Khan Q,S Noor Prevalence, predictors and outcomes of potential drug-drug interactions in left ventricular failure: considerable factors for quality use of medicines, Brazilian Journal of
Pharmaceutical Sciences, 2020 |
16. |
Khan Q Prevalence, predictors and outcomes of potential drug-drug interactions in patients with coronary artery disease: a cross sectional study., Latin american journal of pharmacy, 2019 |
17. |
Inam Ul Haq,Khan Q,S Noor Prevalence, predictors and outcomes of potential drug-drug interactions in patients with coronary artery disease: a cross sectional study, Latin American Journal of Pharmacy, 2019 |
18. |
Khan Q Potential drug-drug interactions in outpatient department of a tertiary care hospital in Pakistan: a cross-sectional study., BMC health services research, 2018 |
19. |
Muhammad Ismail Tajik,S Noor,Khan Q Potential drug-drug interactions in outpatient department of a tertiary care hospital in Pakistan: a cross-sectional study, BMC Health Services Research, 2018 |
20. |
Khan Q Moxifloxacin-induced QT interval prolongation and torsades de pointes: a narrative review., Expert opinion on drug safety, 2018 |
21. |
Khan Q High prevalence of the risk factors for QT interval prolongation and associated drug-drug interactions in coronary care units., Postgraduate medicine, 2018 |
22. |
Khan Q Prevalence of the risk factors for QT prolongation and associated drug-drug interactions in a cohort of medical inpatients., Journal of the Formosan Medical Association, 2018 |
23. |
Khan Q Frequency, characteristics and risk factors of QT interval prolonging drugs and drug-drug interactions in cancer patients: a multicenter study., BMC pharmacology & toxicology, 2017 |
24. |
Khan Q Prevalence of QT interval prolonging drug-drug interactions (QT-DDIs) in psychiatry wards of tertiary care hospitals in Pakistan: a multicenter cross-sectional study., International journal of clinical pharmacy, 2017 |
25. |
Khan Q QT interval prolongation in hospitalized patients on cardiology wards: a prospective observational study, European journal of clinical pharmacology, 2017 |
26. |
Mohammad Ismail Tajik,S Noor,Khan Q Potential drug-drug interactions in pediatric patients admitted to intensive care unit of Khyber Teaching Hospital, Peshawar, Pakistan: A cross-sectional study, Journal of Critical Care, 2017 |
27. |
Khan Q,S Noor QT interval prolongation in hospitalized patients on cardiology wards: a prospective observational study, European Journal of Clinical Pharmacology, 2017 |
28. |
Khan Q Potential drug-drug interactions in pediatric patients admitted to intensive care unit of Khyber Teaching Hospital, Peshawar, Pakistan: A cross-sectional study., Journal of critical care, 2017 |